Esmo Asia 2024 Lba12. At esmo congress 2022, two new agents were added to the list of fgfr inhibitors being investigated, showing some clinical benefits or potential in patients not previously treated with this anticancer drug class. Esmo asia congress 2023 esmo congress 2023 esmo congress virtual platform search thoracic malignancies.

≥2 prior lines of treatment: It provides a platform for participants to share and discuss the latest research findings, clinical trials, and treatment strategies in the field.